Skip to content
Menu

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga Insights 1 hour ago

Movers

Gainers Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out

Gainers

  • Aytu BioPharma (NASDAQ:AYTU) shares rose 45.0% to $2.64 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.7 million. The company's, Q1 earnings came out yesterday.
  • Marker Therapeutics (NASDAQ:MRKR) stock increased by 30.34% to $1.08. The company's market cap stands at $13.8 million. The company's, Q3 earnings came out yesterday.
  • Basel Medical Group (NASDAQ:BMGL) shares increased by 25.8% to $0.38. The company's market cap stands at $4.1 million.
  • Akanda (NASDAQ:AKAN) shares moved upwards by 15.85% to $2.56. The market value of their outstanding shares is at $5.8 million.
  • CEL-SCI (AMEX:CVM) stock rose 13.25% to $1.88. The company's market cap stands at $29.1 million.
  • NeOnc Technologies Hldgs (NASDAQ:NTHI) shares increased by 12.77% to $5.12. The market value of their outstanding shares is at $130.9 million.

Losers

  • SS Innovations Intl (NASDAQ:SSII) shares declined by 14.1% to $1.16 during Tuesday's pre-market session. The market value of their outstanding shares is at $270.6 million.
  • Baird Medical Investment (NASDAQ:BDMD) shares declined by 12.77% to $0.09. The market value of their outstanding shares is at $3.4 million.
  • XORTX Therapeutics (NASDAQ:XRTX) stock decreased by 12.67% to $0.91. The market value of their outstanding shares is at $2.3 million. As per the news, the Q3 earnings report came out yesterday.
  • Insight Molecular (NASDAQ:IMDX) stock fell 11.3% to $1.65. The company's market cap stands at $60.8 million. As per the press release, Q3 earnings came out yesterday.
  • Xtant Medical Holdings (AMEX:XTNT) stock decreased by 9.44% to $0.19. The company's market cap stands at $29.4 million. The company's, Q3 earnings came out yesterday.
  • NewcelX (NASDAQ:NCEL) stock fell 8.37% to $2.52. The company's market cap stands at $15.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Read at benzinga.com